Conclusive evidence shows that ApoE4 contributes to the development of AD, likely through both a loss-of-function in neuroprotection and a gain-of-function in neurotoxicity, when compared to ApoE3 (Huang and Mucke, 2012; Kanekiyo et al., 2014). This evidence concerns the gene APOE and Alzheimer disease.